Cargando…

Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study

BACKGROUND: Adults with chronic kidney disease (CKD) exhibit alterations in tryptophan metabolism, mainly via the kynurenine pathway, due to higher enzymatic activity induced mainly by inflammation. Indoles produced by gut-microflora are another group of tryptophan metabolites related to inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Karu, Naama, McKercher, Charlotte, Nichols, David S., Davies, Noel, Shellie, Robert A., Hilder, Emily F., Jose, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103367/
https://www.ncbi.nlm.nih.gov/pubmed/27832762
http://dx.doi.org/10.1186/s12882-016-0387-3
_version_ 1782466575680405504
author Karu, Naama
McKercher, Charlotte
Nichols, David S.
Davies, Noel
Shellie, Robert A.
Hilder, Emily F.
Jose, Matthew D.
author_facet Karu, Naama
McKercher, Charlotte
Nichols, David S.
Davies, Noel
Shellie, Robert A.
Hilder, Emily F.
Jose, Matthew D.
author_sort Karu, Naama
collection PubMed
description BACKGROUND: Adults with chronic kidney disease (CKD) exhibit alterations in tryptophan metabolism, mainly via the kynurenine pathway, due to higher enzymatic activity induced mainly by inflammation. Indoles produced by gut-microflora are another group of tryptophan metabolites related to inflammation and conditions accompanying CKD. Disruptions in tryptophan metabolism have been associated with various neurological and psychological disorders. A high proportion of CKD patients self-report symptoms of depression and/or anxiety and decline in cognitive functioning. This pilot study examines tryptophan metabolism in CKD and explores associations with psychological and cognitive functioning. METHODS: Twenty-seven adults with CKD were part of 49 patients recruited to participate in a prospective pilot study, initially with an eGFR of 15–29 mL/min/1.73 m(2). Only participants with viable blood samples and complete psychological/cognitive data at a 2-year follow-up were included in the reported cross-sectional study. Serum samples were analysed by Liquid Chromatography coupled to Mass Spectrometry, for tryptophan, ten of its metabolites, the inflammation marker neopterin and the hypothalamic–pituitary–adrenal (HPA) axis marker cortisol. RESULTS: The tryptophan breakdown index (kynurenine / tryptophan) correlated with neopterin (Pearson R = 0.51 P = 0.006) but not with cortisol. Neopterin levels also correlated with indoxyl sulfate (R = 0.68, P < 0.0001) and 5 metabolites of tryptophan (R range 0.5–0.7, all P ≤ 0.01), which were all negatively related to eGFR (P < 0.05). Higher levels of kynurenic acid were associated with lower cognitive functioning (Spearman R = −0.39, P < 0.05), while indole-3 acetic acid (IAA) was correlated with anxiety and depression (R = 0.52 and P = 0.005, R = 0.39 and P < 0.05, respectively). CONCLUSIONS: The results of this preliminary study suggest the involvement of inflammation in tryptophan breakdown via the kynurenine pathway, yet without sparing tryptophan metabolism through the 5-HT (serotonin) pathway in CKD patients. The multiple moderate associations between indole-3 acetic acid and psychological measures were a novel finding. The presented pilot data necessitate further exploration of these associations within a large prospective cohort to assess the broader significance of these findings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-016-0387-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5103367
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51033672016-11-10 Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study Karu, Naama McKercher, Charlotte Nichols, David S. Davies, Noel Shellie, Robert A. Hilder, Emily F. Jose, Matthew D. BMC Nephrol Research Article BACKGROUND: Adults with chronic kidney disease (CKD) exhibit alterations in tryptophan metabolism, mainly via the kynurenine pathway, due to higher enzymatic activity induced mainly by inflammation. Indoles produced by gut-microflora are another group of tryptophan metabolites related to inflammation and conditions accompanying CKD. Disruptions in tryptophan metabolism have been associated with various neurological and psychological disorders. A high proportion of CKD patients self-report symptoms of depression and/or anxiety and decline in cognitive functioning. This pilot study examines tryptophan metabolism in CKD and explores associations with psychological and cognitive functioning. METHODS: Twenty-seven adults with CKD were part of 49 patients recruited to participate in a prospective pilot study, initially with an eGFR of 15–29 mL/min/1.73 m(2). Only participants with viable blood samples and complete psychological/cognitive data at a 2-year follow-up were included in the reported cross-sectional study. Serum samples were analysed by Liquid Chromatography coupled to Mass Spectrometry, for tryptophan, ten of its metabolites, the inflammation marker neopterin and the hypothalamic–pituitary–adrenal (HPA) axis marker cortisol. RESULTS: The tryptophan breakdown index (kynurenine / tryptophan) correlated with neopterin (Pearson R = 0.51 P = 0.006) but not with cortisol. Neopterin levels also correlated with indoxyl sulfate (R = 0.68, P < 0.0001) and 5 metabolites of tryptophan (R range 0.5–0.7, all P ≤ 0.01), which were all negatively related to eGFR (P < 0.05). Higher levels of kynurenic acid were associated with lower cognitive functioning (Spearman R = −0.39, P < 0.05), while indole-3 acetic acid (IAA) was correlated with anxiety and depression (R = 0.52 and P = 0.005, R = 0.39 and P < 0.05, respectively). CONCLUSIONS: The results of this preliminary study suggest the involvement of inflammation in tryptophan breakdown via the kynurenine pathway, yet without sparing tryptophan metabolism through the 5-HT (serotonin) pathway in CKD patients. The multiple moderate associations between indole-3 acetic acid and psychological measures were a novel finding. The presented pilot data necessitate further exploration of these associations within a large prospective cohort to assess the broader significance of these findings. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12882-016-0387-3) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-10 /pmc/articles/PMC5103367/ /pubmed/27832762 http://dx.doi.org/10.1186/s12882-016-0387-3 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Karu, Naama
McKercher, Charlotte
Nichols, David S.
Davies, Noel
Shellie, Robert A.
Hilder, Emily F.
Jose, Matthew D.
Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study
title Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study
title_full Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study
title_fullStr Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study
title_full_unstemmed Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study
title_short Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study
title_sort tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: tasmanian chronic kidney disease pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103367/
https://www.ncbi.nlm.nih.gov/pubmed/27832762
http://dx.doi.org/10.1186/s12882-016-0387-3
work_keys_str_mv AT karunaama tryptophanmetabolismitsrelationtoinflammationandstressmarkersandassociationwithpsychologicalandcognitivefunctioningtasmanianchronickidneydiseasepilotstudy
AT mckerchercharlotte tryptophanmetabolismitsrelationtoinflammationandstressmarkersandassociationwithpsychologicalandcognitivefunctioningtasmanianchronickidneydiseasepilotstudy
AT nicholsdavids tryptophanmetabolismitsrelationtoinflammationandstressmarkersandassociationwithpsychologicalandcognitivefunctioningtasmanianchronickidneydiseasepilotstudy
AT daviesnoel tryptophanmetabolismitsrelationtoinflammationandstressmarkersandassociationwithpsychologicalandcognitivefunctioningtasmanianchronickidneydiseasepilotstudy
AT shellieroberta tryptophanmetabolismitsrelationtoinflammationandstressmarkersandassociationwithpsychologicalandcognitivefunctioningtasmanianchronickidneydiseasepilotstudy
AT hilderemilyf tryptophanmetabolismitsrelationtoinflammationandstressmarkersandassociationwithpsychologicalandcognitivefunctioningtasmanianchronickidneydiseasepilotstudy
AT josematthewd tryptophanmetabolismitsrelationtoinflammationandstressmarkersandassociationwithpsychologicalandcognitivefunctioningtasmanianchronickidneydiseasepilotstudy